Financhill
Buy
64

ENB Quote, Financials, Valuation and Earnings

Last price:
$47.44
Seasonality move :
2.47%
Day range:
$47.35 - $47.64
52-week range:
$39.73 - $50.54
Dividend yield:
5.69%
P/E ratio:
26.00x
P/S ratio:
2.26x
P/B ratio:
2.47x
Volume:
1.2M
Avg. volume:
3.9M
1-year change:
13.33%
Market cap:
$103.6B
Revenue:
$39.1B
EPS (TTM):
$1.82

Earnings Data

Next earnings date for ENB
Feb 13
2026
Most recent earnings per share
$0.23
Missed by $0.14
(Nov 7/2025)
Consensus Estimate
$0.37
(Nov 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ENB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/13/2026 Q4 $9.3B -- -- $0.57 --
11/07/2025 Q3 $8.4B $10.7B $0.23 $0.37 -$0.14
08/01/2025 Q2 $7.8B $10.7B $0.72 $0.41 $0.30
05/09/2025 Q1 $7.4B $12.9B $0.72 $0.69 $0.03
02/14/2025 Q4 $5.4B $11.8B $0.16 $0.52 -$0.36
11/01/2024 Q3 $4.9B $10.9B $0.43 $0.40 $0.03
08/02/2024 Q2 $4.2B $8.3B $0.63 $0.46 $0.17
05/10/2024 Q1 $8.9B $8.1B $0.49 $0.59 -$0.10
02/09/2024 Q4 $9.9B $8.3B $0.60 $0.49 $0.10
11/03/2023 Q3 -- $7.3B $0.19 -- --
06/30/2023 Q2 -- $7.7B $0.68 -- --
03/31/2023 Q1 -- $8.4B $0.63 -- --
12/31/2022 Q4 -- $9.8B -$0.39 -- --
09/30/2022 Q3 -- $9.2B $0.48 -- --
06/30/2022 Q2 -- $10.3B $0.17 -- --
03/31/2022 Q1 -- $11.8B $0.75 -- --
12/31/2021 Q4 -- $9.8B $0.72 -- --
09/30/2021 Q3 -- $9.5B $0.27 -- --
06/30/2021 Q2 -- $8.8B $0.56 -- --
03/31/2021 Q1 -- $9.3B $0.74 -- --
12/31/2020 Q4 -- $7.1B $0.67 -- --
09/30/2020 Q3 -- $6.2B $0.37 -- --
06/30/2020 Q2 -- $6.3B $0.59 -- --
03/31/2020 Q1 -- $8.6B -$0.53 -- --
12/31/2019 Q4 -- $9B $0.27 -- --
09/30/2019 Q3 -- $8.9B $0.36 -- --
06/30/2019 Q2 -- $9.7B $0.64 -- --
03/31/2019 Q1 -- $9.9B $0.70 -- --
12/31/2018 Q4 -- $8.8B $0.41 -- --
09/30/2018 Q3 -- $8.6B -$0.04 -- --
06/30/2018 Q2 -- $8.6B $0.49 -- --
03/31/2018 Q1 -- $10.2B $0.21 -- --
12/31/2017 Q4 -- $10.1B $0.09 -- --
09/30/2017 Q3 -- $7.2B $0.38 -- --
06/30/2017 Q2 -- $8.1B $0.42 -- --
03/31/2017 Q1 -- $8.2B $0.41 -- --
12/31/2016 Q4 -- $7.2B $0.29 -- --
09/30/2016 Q3 -- $6.6B -$0.08 -- --
06/30/2016 Q2 -- $6.2B $0.26 -- --
03/31/2016 Q1 -- $6.2B $1.00 -- --
12/31/2015 Q4 -- $6.6B $0.33 -- --

Enbridge, Inc. Earnings Questions

  • How Much did Enbridge, Inc. Generate in Revenue Last Quarter?

    Enbridge, Inc. reported $10.7B worth of top line sales in its most recent quarter.

  • Did Enbridge, Inc. Beat Earnings Last Quarter?

    Enbridge, Inc. announced earnings per share of $0.23 which represents a miss of analyst forecast a $0.37 per share.

  • Is Enbridge, Inc. Profitable?

    Enbridge, Inc. reported $3.4B that represents $1.55 per share over the last quarter.

  • What is the Analyst Consensus for Enbridge, Inc. EPS Next Year?

    Enbridge, Inc.'s earnings are forecast to grow from $1.71 per share to $1.95 per share next year representing an increase of 25.06%.

  • When is Enbridge, Inc.'s Earnings Date?

    Enbridge, Inc.'s next earnings date is February 13, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock